MedTrace Logo

30 Day Rehospitalization Risk in Hemodialysis Patients

NCT02553564 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2018-04-02

No results posted yet for this study

Summary

After a hospitalization, dialysis patients have a high risk of being admitted to the hospital again within 30 days. The purpose of this research study is to test a new way of reducing the chance of patients being hospitalized again. In this study investigator will evaluate a checklist driven evaluation upon return to the dialysis facility as a method to reduce the rate of rehospitalizations in hemodialysis patients.

Conditions

  • Re-hospitalization Hemodialysis

Interventions

OTHER

Checklist driven clinical encounter after hospital discharge

Within 96 hours of hospital discharge an Nurse Practitioner will perform a checklist guided assessment to preventing rehospitalizations. The assessment consists of the following: 1. The participants's hospital course will be reviewed and their clinical recovery and stability assessed. 2. Determination of the participants's estimated dry weight (EDW). 3. The participants's post discharge medications will be checked, compared to the prehospitalization medication, and discrepancies will be reviewed and corrected. 4. Blood tests will be ordered for the participants's first return dialysis treatment if medically appropriate after clinical assessment. 5. Write new dialysis orders. 6. Dialysis Access- review access and determine any changes required in treatment

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Steven Fishbane, MD · Northshore-LIJ health system

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-22
Primary Completion
2018-03-15
Completion
2018-03-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02553564 on ClinicalTrials.gov